119 related articles for article (PubMed ID: 2845259)
1. Lambert-Eaton myasthenic syndrome: a review.
Newsom-Davis J
Monogr Allergy; 1988; 25():116-24. PubMed ID: 2845259
[TBL] [Abstract][Full Text] [Related]
2. Lambert-Eaton myasthenic syndrome: immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity.
Lang B; Vincent A; Murray NM; Newsom-Davis J
Ann Neurol; 1989 Mar; 25(3):265-71. PubMed ID: 2543262
[TBL] [Abstract][Full Text] [Related]
3. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
Takamori M
J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
[TBL] [Abstract][Full Text] [Related]
4. Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation.
Nagel A; Engel AG; Lang B; Newsom-Davis J; Fukuoka T
Ann Neurol; 1988 Oct; 24(4):552-8. PubMed ID: 2853605
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder.
Vincent A; Lang B; Newsom-Davis J
Trends Neurosci; 1989 Dec; 12(12):496-502. PubMed ID: 2480664
[TBL] [Abstract][Full Text] [Related]
6. Lambert-Eaton myasthenic syndrome: electrophysiological evidence for a humoral factor.
Newsom-Davis J; Murray N; Wray D; Lang B; Prior C; Gwilt M; Vincent A
Muscle Nerve; 1982; 5(9S):S17-20. PubMed ID: 6302493
[TBL] [Abstract][Full Text] [Related]
7. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
8. Diseases of the myoneural junction.
Newsom-Davis J
Res Publ Assoc Res Nerv Ment Dis; 1990; 68():233-40. PubMed ID: 1691520
[TBL] [Abstract][Full Text] [Related]
9. [Lambert-Eaton syndrome and myasthenia. Nosologic discussion].
Marion JL; Pennec Y; Mottier D; Le Menn G
Sem Hop; 1984 Jan; 60(1):43-5. PubMed ID: 6320432
[TBL] [Abstract][Full Text] [Related]
10. [Lambert-Eaton myasthenic syndrome: diagnosis and treatment].
Motomura M; Iwanaga H
Clin Calcium; 2001 Nov; 11(11):1468-74. PubMed ID: 15775666
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical characteristics of small cell lung carcinoma associated with the Lambert-Eaton myasthenic syndrome.
Morris CS; Esiri MM; Marx A; Newsom-Davis J
Am J Pathol; 1992 Apr; 140(4):839-45. PubMed ID: 1314026
[TBL] [Abstract][Full Text] [Related]
12. SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma.
Lipka AF; Verschuuren JJ; Titulaer MJ
Ann N Y Acad Sci; 2012 Dec; 1275():70-7. PubMed ID: 23278580
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line.
Roberts A; Perera S; Lang B; Vincent A; Newsom-Davis J
Nature; 1985 Oct 24-30; 317(6039):737-9. PubMed ID: 2414666
[TBL] [Abstract][Full Text] [Related]
14. [Small cell lung cancer with Lambert-Eaton myasthenic syndrome].
Tang XF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Feb; 22(1):17-9, 61. PubMed ID: 2553355
[TBL] [Abstract][Full Text] [Related]
15. Lambert-Eaton myasthenic syndrome.
Newsom-Davis J
Springer Semin Immunopathol; 1985; 8(1-2):129-40. PubMed ID: 2988146
[TBL] [Abstract][Full Text] [Related]
16. Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
Pellkofer HL; Armbruster L; Krumbholz M; Titulaer MJ; Verschuuren JJ; Schumm F; Voltz R
J Neuroimmunol; 2008 Nov; 204(1-2):136-9. PubMed ID: 18809213
[TBL] [Abstract][Full Text] [Related]
17. Autonomic dysfunction in Lambert-Eaton myasthenic syndrome.
Khurana RK; Koski CL; Mayer RF
J Neurol Sci; 1988 May; 85(1):77-86. PubMed ID: 2838585
[TBL] [Abstract][Full Text] [Related]
18. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival.
Titulaer MJ; Klooster R; Potman M; Sabater L; Graus F; Hegeman IM; Thijssen PE; Wirtz PW; Twijnstra A; Smitt PA; van der Maarel SM; Verschuuren JJ
J Clin Oncol; 2009 Sep; 27(26):4260-7. PubMed ID: 19667272
[TBL] [Abstract][Full Text] [Related]
19. Lambert-Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end-plate.
Fukuoka T; Engel AG; Lang B; Newsom-Davis J; Vincent A
Ann Neurol; 1987 Aug; 22(2):200-11. PubMed ID: 3310854
[TBL] [Abstract][Full Text] [Related]
20. SOX1 autoantibodies: tumor markers in LEMS patients?
Lang B; Evoli A
Neurology; 2008 Mar; 70(12):906-7. PubMed ID: 18347313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
